Oncologic emergencies and urgencies: A comprehensive review
BE Gould Rothberg, TE Quest… - CA: a cancer journal …, 2022 - Wiley Online Library
Patients with advanced cancer generate 4 million visits annually to emergency departments
(EDs) and other dedicated, high‐acuity oncology urgent care centers. Because of both the …
(EDs) and other dedicated, high‐acuity oncology urgent care centers. Because of both the …
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
MN Meriggioli, DB Sanders - The Lancet Neurology, 2009 - thelancet.com
Acquired myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction
in which patients experience fluctuating skeletal muscle weakness that often affects selected …
in which patients experience fluctuating skeletal muscle weakness that often affects selected …
Thymoma and autoimmunity
S Shelly, N Agmon-Levin, A Altman… - Cellular & molecular …, 2011 - nature.com
The thymus is a central lymphatic organ that is responsible for many immunological
functions, including the production of mature, functional T cells and the induction of self …
functions, including the production of mature, functional T cells and the induction of self …
Muscle autoantibodies in myasthenia gravis: beyond diagnosis?
MN Meriggioli, DB Sanders - Expert review of clinical immunology, 2012 - Taylor & Francis
Myasthenia gravis is an autoimmune disorder of the neuromuscular junction. A number of
molecules, including ion channels and other proteins at the neuromuscular junction, may be …
molecules, including ion channels and other proteins at the neuromuscular junction, may be …
Autoimmune targets of heart and skeletal muscles in myasthenia gravis
S Suzuki, K Utsugisawa, H Yoshikawa… - Archives of …, 2009 - jamanetwork.com
Objective To investigate the clinical, histological, and immunological features of patients with
myasthenia gravis (MG) who also developed myocarditis and/or myositis. Design …
myasthenia gravis (MG) who also developed myocarditis and/or myositis. Design …
Cardiac toxicity associated with immune checkpoint inhibitors: a systematic review
A Cozma, ND Sporis, AL Lazar, A Buruiana… - International Journal of …, 2022 - mdpi.com
Immune checkpoint inhibitors (ICIs) are an important advancement in the field of cancer
treatment, significantly improving the survival of patients with a series of advanced …
treatment, significantly improving the survival of patients with a series of advanced …
Three types of striational antibodies in myasthenia gravis
S Suzuki, K Utsugisawa, Y Nagane… - Autoimmune …, 2011 - Wiley Online Library
Myasthenia gravis (MG) is caused by antibodies that react mainly with the acetylcholine
receptor on the postsynaptic site of the neuromuscular junction. A wide range of clinical …
receptor on the postsynaptic site of the neuromuscular junction. A wide range of clinical …
Pathophysiology of myasthenia gravis
BW Hughes, MLM De Casillas… - Seminars in …, 2004 - thieme-connect.com
Myasthenia gravis (MG) is arguably the best understood autoimmune disease, and its study
has also led to fundamental appreciation of mechanisms of neuromuscular transmission …
has also led to fundamental appreciation of mechanisms of neuromuscular transmission …
Cardiac involvements in myasthenia gravis associated with anti‐K v1. 4 antibodies
Background and purpose There is no general consensus as to whether autoimmune
myasthenia gravis (MG) is associated with heart diseases, despite the fact that myocarditis, a …
myasthenia gravis (MG) is associated with heart diseases, despite the fact that myocarditis, a …
Myokymia and neuromyotonia 2004.
L Gutmann, L Gutmann - Journal of neurology, 2004 - search.ebscohost.com
Myokymia and neuromyotonia 2004 Page 1 J Neurol (2004) 251 : 138 –142 DOI 10.1007/s00415-004-0331-5
ENS TEACHING REVIEW Ludwig Gutmann Laurie Gutmann Myokymia and neuromyotonia …
ENS TEACHING REVIEW Ludwig Gutmann Laurie Gutmann Myokymia and neuromyotonia …